
WHO approves first infant-focused malaria treatment and expands rapid diagnostics
WHO prequalified the first malaria treatment for newborns and young infants (artemether-lumefantrine) and added three rapid diagnostic tests that use pf-LDH to detect malaria where HRP2-based tests miss cases, helping close a long-standing treatment gap for about 30 million babies born each year and improving diagnosis in HRP2-deletion areas ahead of World Malaria Day 2026.
